How to Navigate the Biotech Startup Network
Friday, January 28, 2022 at 3:00pm to 5:00pmVirtual Event
Ohad Yosefson, PhD, Associate Director of Protein Sciences, Repertoire Immune Medicines
Nathan Young, PhD, Associate Director of Molecular and Cellular Oncology, Ikena Oncology
Megan Warner, PhD, Senior Scientist, Protein Sciences, CRISPR Therapeutics
The Boston biotech sector is booming with scientific innovation, investments, and company creation. In this session, we will chat with scientists from three different biotech companies to learn how to navigate a career in a constantly evolving company while managing expectations and responsibilities. Learn about their previous experiences and job roles and inquire about their thoughts on the biotech landscape.
Repertoire Immune Medicines is a series B funded Flagship Pioneering company seeking to rationally engineer T cell receptor (TCR)-antigen interactions. Ikena Oncology is a public company focusing on genetically defined or biomarker-driven cancer targets. CRISPR Therapeutics is a public gene editing company developing treatments for hemoglobinopathies, cancer, and diabetes. All three are clinical-stage companies at the frontline of innovation.
Session organizer: Fiona Aguilar
Tentative: hybrid mode 68-181
Otherwise, Zoom link: https://mit.zoom.us/j/95349775648